Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
Asad Bashey, Mary Eapen(Medical College of Wisconsin), Vanderson Rocha(Université Paris Cité), Mehdi Hamadani(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Trevor Argall(Johns Hopkins Hospital), Rachel B. Salit(Johns Hopkins Hospital), Monzr M. Al Malki(Johns Hopkins Hospital), Paul V. O’Donnell(Johns Hopkins Hospital), Pashna N. Munshi(Johns Hopkins Hospital), Claudio Anasetti(Johns Hopkins Hospital), Scott D. Rowley(Johns Hopkins Hospital), Rizwan Romee(Harvard University), Ephraim J. Fuchs(Johns Hopkins Hospital), Robert J. Soiffer(Dana-Farber Cancer Institute), Shannon R. McCurdy(Johns Hopkins Hospital), Sameh Gaballa(Johns Hopkins Hospital), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Andrew St. Martin(Johns Hopkins Hospital), Ryotaro Nakamura(City of Hope), Omotayo Fasan(Bristol-Myers Squibb (United States)), Stefan O. Ciurea(The University of Texas MD Anderson Cancer Center), Kavita Raj(Johns Hopkins Hospital), Mei-Jie Zhang(Johns Hopkins Hospital), Melhem Solh(Johns Hopkins Hospital)
Cited by 325
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
|Science Translational Medicine|2016|916